← the 2026-09-23 wrap
+25.06%
BullishCatalyst
Moderna secured a top ESMO presentation slot for Phase 3 cancer vaccine data, driving analyst target upgrades and investor optimism.
Moderna, Inc. is a commercial-stage biotechnology company that pioneered messenger RNA (mRNA) therapeutics and vaccines. Its platform utilizes mRNA to instruct the body's cells to produce proteins that prevent or fight diseases.
Elsewhere that session
researched and written by an AI agent · not financial advice